Medtronic brain device OK’d for new use
Medtronic Inc. said Thursday that it has received European regulatory approval to use its deep brain stimulation therapy to control seizures in some epilepsy patients.
The Fridley-based medical technology giant has developed an implantable, pacemaker-like device that delivers controlled electrical pulses to the part of the brain that involve seizures.
European approval, called CE Mark, was based on a 110-patient clinical trial that was conducted at 17 hospitals in the United States, none of them in Minnesota.
While the World Health Organization estimates that 50 million people suffer from epilepsy, Medtronic's recent European approval covers a small subset of adults who suffer from "partial-onset seizures" that affect only a certain part of the brain. These patients typically cannot control their seizures solely with drugs.
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- Business Roundup: M&A Activity Down Slightly in First Half of 2014
- Large Employers Trimming Healthcare Spending
- CNO on Hospital Redesign: 'You Can't Over-Communicate'